Meetings to be held on the West Coast January 30-31 hosted by Truist.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on CRBU:
- Edgewise, Caribou higher after WSJ report of Cytokinetics buyout
- Allogene Therapeutics price target lowered to $17 from $18 at Truist
- Caribou Biosciences price target lowered to $21 from $23 at Truist
- Caribou Biosciences Appoints Tim Kelly as Chief Technology Officer and Highlights Multiple Clinical Catalysts Expected in 2024
- Caribou Biosciences provides regulatory update on CB-010 development program